The PROMISE Study: Screening for Multiple Myeloma in High-Risk Individuals
1,635 views · Published 17 October 2018 · 3:38 · Indexed 18 October 2026
Channel: Dana-Farber Cancer Institute · 2018 · Science & Technology
Dana-Farber's Dr. Irene Ghobrial provides an overview of the PROMISE study, the first-ever screening study of high risk individuals for MGUS and SMM, blood conditions that often precede multiple myeloma, an incurable blood cancer. High risk individuals are those who are 45-75 years old and are African American or have a first degree relative with multiple myeloma. Learn more about this study and how to find out if you should participate at www.promisestudy.org.
More from this channel
-
0:18
Importance of Joining the Stem Cell Registry | Dana-Farber Cancer Institute
-
0:20
How to Join the Stem Cell Registry | Dana-Farber Cancer Institute
-
0:18
How to Register as a Stem Cell Donor | Dana-Farber Cancer Institute
-
3:03
Sportscaster Jim Britt for the Jimmy Fund | Dana-Farber Cancer Institute
-
0:07
Dana-Farber Banners | Dana-Farber Cancer Institute
-
2:08
Barbers for the Jimmy Fund | Dana-Farber Cancer Institute
-
1:43
Pets | Dana-Farber Cancer Institute
-
1:34
Healthy Eating for the Holiday Season | Dana-Farber Cancer Institute